4,4,5,5-Tetramethyl-2-[3-(triphenylen-2-yl)phenyl]-1,3,2-dioxaborolane ≥99%
T396386-1g / 1g
CAS:1115639-92-3
4,4,5,5-Tetramethyl-2-[3-(triphenylen-2-yl)phenyl]-1,3,2-dioxaborolane ≥99%
T396386-200mg / 200mg
CAS:1115639-92-3
trans-Di(μ-acetato)bis[o-(di-o-tolylphosphino)benzyl]dipalladium(II) ≥97%, cataCXium® C
T396609-1g / 1g
CAS:172418-32-5
trans-Di(μ-acetato)bis[o-(di-o-tolylphosphino)benzyl]dipalladium(II) ≥97%, cataCXium® C
T396609-250mg / 250mg
CAS:172418-32-5
trans-Di(μ-acetato)bis[o-(di-o-tolylphosphino)benzyl]dipalladium(II) ≥97%, cataCXium® C
T396609-5g / 5g
CAS:172418-32-5
Tris(1,10-phenanthroline)ruthenium(II) Bis(hexafluorophosphate) ≥95%
T396648-250mg / 250mg
CAS:60804-75-3
Tris(1,10-phenanthroline)ruthenium(II) Bis(hexafluorophosphate) ≥95%
T396648-50mg / 50mg
CAS:60804-75-3
1-(2,4,6-Trimethylphenyl)-2-(dicyclohexylphosphino)imidazole ≥95%, cataCXium® PlCy
T396680-2g / 2g
CAS:794527-14-3
1-(2,4,6-Trimethylphenyl)-2-(dicyclohexylphosphino)imidazole ≥95%, cataCXium® PlCy
T396680-500mg / 500mg
CAS:794527-14-3